Literature DB >> 19372173

The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?

Jean Klastersky1.   

Abstract

Why empirical therapy? Because it works! Empirical antimicrobial therapy is a reasonable, pragmatic approach to limit the ominous threat of Gram-negative sepsis in febrile neutropenic cancer patients. Empirical treatment of occult fungal infection in patients with neutropenia and persistent fever, in spite of initial broad-spectrum antimicrobial coverage, is effective but the role of pre-emptive treatment remains to be established.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372173     DOI: 10.1093/jac/dkp075

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia.

Authors:  Nagua Giurici; Giulio A Zanazzo
Journal:  Pediatr Rep       Date:  2011-02-24

2.  Time to antibiotics and outcomes in cancer patients with febrile neutropenia.

Authors:  Thomas Perron; Mohamed Emara; Shahid Ahmed
Journal:  BMC Health Serv Res       Date:  2014-04-10       Impact factor: 2.655

3.  Identification and Distribution of Pathogens in a Major Tertiary Hospital of Indonesia.

Authors:  Nyoman Sri Budayanti; Dewi N Aisyah; Nengah N D Fatmawati; Ni M A Tarini; Zisis Kozlakidis; Wiku Adisasmito
Journal:  Front Public Health       Date:  2020-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.